3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
2
Lung Neoplasms
2
Sarcoma
1
Neuroblastoma
1
Neoplasms
1
Lymphoma, Large-Cell, Anaplastic
1
Granuloma, Plasma Cell
1
Interventions
pazopanib
2
Ifosfamide
2
Doxorubicin
2
selinexor
1
ceritinib
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Crizotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Granuloma, Plasma Cell
×
ceritinib
×
90 days
×
Clear all
NCT05100134
2026-04-01
Managed Access Programs for LDK378, Ceritinib
Novartis
No longer available